Attorneys are predicting that hundreds of Actos lawsuits could be filed against its manufacturer by patients who developed bladder cancer after taking the drug. In June 2011, the Food and Drug Administration warned that patients taking Actos for more than one year or at higher doses faced an increased risk of developing bladder cancer.
Actos lawyers say that they have already spoken to dozens of clients who wish to file a lawsuit. Some experts are predicting that the total number of Actos lawsuits over bladder cancer could eventually number into the thousands.
Actos became the most widely prescribed diabetes treatment in the US after the former leader, Avandia, was linked to an increased risk of heart attack and cardiovascular problems. Industry analysts now say that other drugs could become more frequently prescribed due to concerns about bladder cancer from taking Actos.
After researchers found that Actos could increase a patient’s risk of bladder cancer, health officials in France and Germany ordered the drug pulled from sale in those countries. Despite the FDA’s warning about Actos, the agency has not announced any plans to recall the drug.